Cefalexin 250mg tablets

Země: Velká Británie

Jazyk: angličtina

Zdroj: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktivní složka:

Cefalexin

Dostupné s:

Flynn Pharma Ltd

ATC kód:

J01DB01

INN (Mezinárodní Name):

Cefalexin

Dávkování:

250mg

Léková forma:

Oral tablet

Podání:

Oral

Třída:

No Controlled Drug Status

Druh předpisu:

Valid as a prescribable product

Přehled produktů:

BNF: 05010201; GTIN: 5060106551368

Informace pro uživatele

PACKAGE LEAFLET: INFORMATION FOR THE USER
CEFALEXIN TABLETS 250 MG
CEFALEXIN TABLETS 500 MG
CEFALEXIN
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START
TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.
■
Keep this leaflet. You may need to read it again.
■
If you have any further questions, ask your doctor
or pharmacist.
■
This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them, even if
their signs of illness are the same as yours.
■
If you get any side effects, talk to your doctor or
pharmacist. This includes any possible side effects
not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1. WHAT CEFALEXIN IS AND WHAT IT IS USED FOR
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE CEFALEXIN
3. HOW TO TAKE CEFALEXIN
4. POSSIBLE SIDE EFFECTS
5. HOW TO STORE CEFALEXIN
6. CONTENTS OF THE PACK AND OTHER INFORMATION
1 WHAT CEFALEXIN IS AND WHAT IT IS USED FOR
Cefalexin contains the active ingredient cefalexin
monohydrate, which is an antibiotic.
Cefalexin is used to treat the following infections caused
by bacteria that can be killed by cefalexin:
■
Respiratory tract (lung and airways) infections
e.g. tonsillitis, pharyngitis and bronchitis
■
Middle ear infection (otitis media)
■
Skin and soft tissue (e.g. muscle) infections
■
Bone and joint infections
■
Infections of the reproductive organs and urinary
tract (e.g. cystitis), including acute inflammation of the
prostate (prostatitis)
■
Dental infections.
2 WHAT YOU NEED TO KNOW BEFORE YOU
TAKE CEFALEXIN
DO NOT TAKE CEFALEXIN:
■
If you are allergic to cefalexin, other cephalosporins
(similar antibiotics) or any of the other ingredients of
this medicine (listed in Section 6). An allergic reaction
may include rash, itching, difficulty breathing or
swelling of the face, lips, throat or tongue.
WARNINGS AND PRECAUTIONS
Talk to your doctor or pharmacist before taking Cefalexin
if you:
■
have had an allergic reaction to cefalexin,
cephalosporins, penicillins, or other drugs in the past
�

Charakteristika produktu

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Keflex Tablets 250 mg
Cefalexin 250 mg Tablets.
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains as the active ingredient, cefalexin monohydrate
equivalent to
250mg of cefalexin base.
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Tablet
9.5 mm diameter, peach, marked ‘GP3’.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Cefalexin is a semisynthetic cephalosporin antibiotic for oral
administration.
Cefalexin is indicated in the treatment of the following infections
due to
susceptible micro-organisms:
Respiratory tract infections.
Otitis media.
Skin and soft tissue infections.
Bone and joint infections.
Genito-urinary tract infections, including acute prostatitis.
Dental infections.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Adults _
The adult dosage ranges from 1-4g daily in divided doses; most
infections will respond
to a dosage of 500 mg every 8 hours. For skin and soft tissue
infections, streptococcal
pharyngitis and mild, uncomplicated urinary tract infections, the
usual dosage is
250 mg every 6 hours, or 500 mg every 12 hours.
For more severe infections or those caused by less susceptible
organisms, larger doses
may be needed. If daily doses of cefalexin greater than 4g are
required, parenteral
cephalosporins, in appropriate doses, should be considered.
_The elderly and patients with impaired renal function _
As for adults. Reduce dosage if renal function is markedly impaired
(see section 4.4).
_ _
_Paediatric population _
The usual recommended daily dosage for children is 25-50 mg/kg (10-20
mg/lb) in
divided doses. For skin and soft tissue infections, streptococcal
pharyngitis and mild,
uncomplicated urinary tract infections, the total daily dose may be
divided and
administered every 12 hours. For most infections the following
schedule is suggested:
_Children under 5 years: _
125 mg every 8 hours.
_Children 5 years and over: _
250 mg every 8 hours.
In severe infections, the dosage may